Literature DB >> 26524151

NSAID-induced Gastrointestinal Injury: A Focused Update for Clinicians.

James M Scheiman1.   

Abstract

Gastroenterologists care for users of nonsteroidal anti-inflammatory drugs (NSAIDs) when the vast population exposed to the medication class experiences a relatively uncommon serious gastrointestinal (GI) side effect. As serious adverse cardiovascular (CV) effects of these drugs have also been recognized, there remains continued confusion about the best treatment for patients who benefit from NSAID therapy and are at risk for GI and CV adverse events. Recognition of those patients at risk and strategies to reduce the adverse side effects of NSAIDs continues to provide an opportunity to improve patient outcomes. This review discusses the injury induced by these agents throughout the GI tract as well as strategies to prevent acute injury and reduce the development of serious adverse events. NSAID medication selection as well as GI cotherapy should balance individual patients' GI and CV risks.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26524151     DOI: 10.1097/MCG.0000000000000432

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  18 in total

1.  Strategic Targeting of Multiple BMP Receptors Prevents Trauma-Induced Heterotopic Ossification.

Authors:  Shailesh Agarwal; Shawn J Loder; Christopher Breuler; John Li; David Cholok; Cameron Brownley; Jonathan Peterson; Hsiao H Hsieh; James Drake; Kavitha Ranganathan; Yashar S Niknafs; Wenzhong Xiao; Shuli Li; Ravindra Kumar; Ronald Tompkins; Michael T Longaker; Thomas A Davis; Paul B Yu; Yuji Mishina; Benjamin Levi
Journal:  Mol Ther       Date:  2017-07-15       Impact factor: 11.454

2.  Risk of gastrointestinal events among patients with sarcoidosis: a population-based study 1976-2013.

Authors:  Patompong Ungprasert; Cynthia S Crowson; Eric L Matteson
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

3.  The ACTTION-APS-AAPM Pain Taxonomy (AAAPT) Multidimensional Approach to Classifying Acute Pain Conditions.

Authors:  Michael L Kent; Patrick J Tighe; Inna Belfer; Timothy J Brennan; Stephen Bruehl; Chad M Brummett; Chester C Buckenmaier; Asokumar Buvanendran; Robert I Cohen; Paul Desjardins; David Edwards; Roger Fillingim; Jennifer Gewandter; Debra B Gordon; Robert W Hurley; Henrik Kehlet; John D Loeser; Sean Mackey; Samuel A McLean; Rosemary Polomano; Siamak Rahman; Srinivasa Raja; Michael Rowbotham; Santhanam Suresh; Bernard Schachtel; Kristin Schreiber; Mark Schumacher; Brett Stacey; Steven Stanos; Knox Todd; Dennis C Turk; Steven J Weisman; Christopher Wu; Daniel B Carr; Robert H Dworkin; Gregory Terman
Journal:  J Pain       Date:  2017-05       Impact factor: 5.820

4.  Pharmacokinetics, Safety, and Tolerability of Intravenous Felbinac Trometamol in Healthy Chinese Volunteers: A First-in-Human Single- and Multiple-Dose Escalation Phase I Study with a Randomized, Double-Blind, Placebo-Controlled Design.

Authors:  Min Wu; Cuiyun Li; Hong Zhang; Jixuan Sun; Xiaoxue Zhu; Xiaojiao Li; Xuedong Gao; Wei Wang; Yanhua Ding
Journal:  CNS Drugs       Date:  2020-08       Impact factor: 5.749

5.  Monoacylglycerol lipase inhibitor JZL184 prevents HIV-1 gp120-induced synapse loss by altering endocannabinoid signaling.

Authors:  Xinwen Zhang; Stanley A Thayer
Journal:  Neuropharmacology       Date:  2017-10-20       Impact factor: 5.250

Review 6.  Loxoprofen: A Review in Pain and Inflammation.

Authors:  Sarah L Greig; Karly P Garnock-Jones
Journal:  Clin Drug Investig       Date:  2016-09       Impact factor: 2.859

7.  The ACTTION-APS-AAPM Pain Taxonomy (AAAPT) Multidimensional Approach to Classifying Acute Pain Conditions.

Authors:  Michael L Kent; Patrick J Tighe; Inna Belfer; Timothy J Brennan; Stephen Bruehl; Chad M Brummett; Chester C Buckenmaier; Asokumar Buvanendran; Robert I Cohen; Paul Desjardins; David Edwards; Roger Fillingim; Jennifer Gewandter; Debra B Gordon; Robert W Hurley; Henrik Kehlet; John D Loeser; Sean Mackey; Samuel A McLean; Rosemary Polomano; Siamak Rahman; Srinivasa Raja; Michael Rowbotham; Santhanam Suresh; Bernard Schachtel; Kristin Schreiber; Mark Schumacher; Brett Stacey; Steven Stanos; Knox Todd; Dennis C Turk; Steven J Weisman; Christopher Wu; Daniel B Carr; Robert H Dworkin; Gregory Terman
Journal:  Pain Med       Date:  2017-05-01       Impact factor: 3.750

8.  Effect of Ketoprofen and ATB-352 on the Immature Human Intestine: Identification of Responders and Non-responders.

Authors:  Marie-Pier Thibault; Éric Tremblay; John L Wallace; Jean-François Beaulieu
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-05       Impact factor: 2.839

9.  Novel NSAID-Derived Drugs for the Potential Treatment of Alzheimer's Disease.

Authors:  Ivana Cacciatore; Lisa Marinelli; Erika Fornasari; Laura S Cerasa; Piera Eusepi; Hasan Türkez; Cristina Pomilio; Marcella Reale; Chiara D'Angelo; Erica Costantini; Antonio Di Stefano
Journal:  Int J Mol Sci       Date:  2016-06-30       Impact factor: 5.923

10.  Protective Effects of Methanol Extract of Vernonia amygdalina (del.) Leaf on Aspirin-Induced Gastric Ulceration and Oxidative Mucosal Damage in a Rat Model of Gastric Injury.

Authors:  Modinat A Adefisayo; Rufus O Akomolafe; Olumide S Akinsomisoye; Quadri K Alabi; Laofe Ogundipe; Joseph G Omole; Kehinde P Olamilosoye
Journal:  Dose Response       Date:  2018-07-08       Impact factor: 2.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.